Monoclonal antibody capable of binding to specific discontinuous epitope occurring in AD1 region of human cytomegalovirus gB glycoprotein, and antigenbinding fragment thereof

Details for Australian Patent Application No. 2010232202 (hide)

Owner Evec Incorporated

Inventors Takada, Kenzo; Kurino, Rika; Torashima, Takashi

Agent FB Rice

Pub. Number AU-A-2010232202

PCT Pub. Number WO2010/114106

Priority 2009-089442 01.04.09 JP

Filing date 1 April 2010

Wipo publication date 7 October 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 16/08 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from viruses

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

27 October 2011 PCT application entered the National Phase

  PCT publication WO2010/114106 Priority application(s): WO2010/114106

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010232219-Speech encoding device, speech decoding device, speech encoding method, speech decoding method, speech encoding program, and speech decoding program

2010232180-Method for prophylaxis of influenza using vaccine for intranasal administration